Lifang Liu

431 total citations
20 papers, 312 citations indexed

About

Lifang Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lifang Liu has authored 20 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lifang Liu's work include Cancer-related molecular mechanisms research (3 papers), Metastasis and carcinoma case studies (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lifang Liu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Metastasis and carcinoma case studies (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lifang Liu collaborates with scholars based in China, United States and Sweden. Lifang Liu's co-authors include Jens Nielsen, Dina Petranović, Zihe Liu, José L. Martínez, Anqi Ge, Zijun Li, Ruifeng Li, Meng Fan, Kailin Yang and Dong Ma and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Medicine.

In The Last Decade

Lifang Liu

18 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifang Liu China 10 150 60 52 46 30 20 312
Xiaochun Xia China 10 193 1.3× 59 1.0× 86 1.7× 26 0.6× 26 0.9× 22 304
Zifei Yin China 14 212 1.4× 42 0.7× 61 1.2× 34 0.7× 9 0.3× 36 423
Baojin Wang China 12 169 1.1× 36 0.6× 112 2.2× 37 0.8× 20 0.7× 25 319
Jingmin Che China 10 173 1.2× 82 1.4× 54 1.0× 94 2.0× 20 0.7× 22 377
Gaby Wangorsch Germany 11 152 1.0× 58 1.0× 37 0.7× 20 0.4× 14 0.5× 17 427
Ki‐Hoon Song South Korea 10 249 1.7× 101 1.7× 44 0.8× 25 0.5× 60 2.0× 31 427
Yue Shang China 13 292 1.9× 91 1.5× 55 1.1× 24 0.5× 47 1.6× 39 487
Nayer Seyfizadeh Iran 10 116 0.8× 40 0.7× 45 0.9× 24 0.5× 26 0.9× 17 289
Miyako Okamoto United States 6 294 2.0× 87 1.4× 32 0.6× 38 0.8× 21 0.7× 6 502
Zhenyang Liu China 11 194 1.3× 71 1.2× 74 1.4× 21 0.5× 12 0.4× 33 321

Countries citing papers authored by Lifang Liu

Since Specialization
Citations

This map shows the geographic impact of Lifang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Liu more than expected).

Fields of papers citing papers by Lifang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Liu. The network helps show where Lifang Liu may publish in the future.

Co-authorship network of co-authors of Lifang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lifang Liu. A scholar is included among the top collaborators of Lifang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifang Liu. Lifang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Juan, et al.. (2025). Rat Model of Granulomatous Mastitis. Journal of Inflammation Research. Volume 18. 9443–9457.
2.
Zhou, Yao, et al.. (2025). The role of macrophages in hypertrophic scarring: molecular to therapeutic insights. Frontiers in Immunology. 16. 1503985–1503985. 5 indexed citations
3.
Zhang, Xiang Dong, Lixing Zhou, Jiao Liu, et al.. (2024). Genetic analysis of a novel <i>FBN1</i> mutation in a pediatric Marfan syndrome patient. Intractable & Rare Diseases Research. 13(3). 178–184.
4.
Liu, Lifang, et al.. (2023). Novel heterozygous mutation in the SHOX gene leading to familial idiopathic short stature: A case report and literature review. Medicine. 102(41). e35471–e35471. 2 indexed citations
5.
Ge, Anqi, Qi He, Zhao Da, et al.. (2023). Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. Journal of Cellular and Molecular Medicine. 28(1). e18044–e18044. 16 indexed citations
6.
Wang, Yue, et al.. (2022). Differential expression profiles of miRNA in granulomatous lobular mastitis and identification of possible biomarkers. Experimental and Therapeutic Medicine. 24(2). 500–500. 7 indexed citations
8.
Guo, Qianqian, Meaghan Coyle, Anthony Lin Zhang, et al.. (2022). Chinese Medicine Syndrome Differentiation for Early Breast Cancer: A Multicenter Prospective Clinical Study. Frontiers in Oncology. 12. 914805–914805. 6 indexed citations
9.
Ge, Anqi, et al.. (2021). Exploring the Mechanism of Baicalin Intervention in Breast Cancer Based on MicroRNA Microarrays and Bioinformatics Strategies. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 7 indexed citations
10.
Liu, Lifang, et al.. (2021). Inhibition of Notch signaling pathway reduces angiogenesis in hypertrophic scar.. PubMed. 46(11). 1195–1202. 3 indexed citations
11.
Qian, Xuejun, Bo Zhang, Xiaoqiong Chen, et al.. (2020). A combined ultrasonic B-mode and color Doppler system for the classification of breast masses using neural network. European Radiology. 30(5). 3023–3033. 26 indexed citations
13.
Liu, Lifang, et al.. (2019). Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8. Anti-Cancer Agents in Medicinal Chemistry. 19(8). 1021–1028. 15 indexed citations
14.
Fan, Meng, Ruifeng Li, Lifang Liu, et al.. (2019). Porphyromonas gingivalis promotes the motility of esophageal squamous cell carcinoma by activating NF-κB signaling pathway. Microbes and Infection. 21(7). 296–304. 46 indexed citations
15.
Liu, Lifang, et al.. (2018). Spectrometric Studies on Sodium Nitroprusside and its Interaction with HSA upon Photoirradiation. 3(2). 1–6. 2 indexed citations
16.
Liu, Lifang, et al.. (2018). [Expression of vascular relevant factors in rabbits with deep II degree burn based on the Notch signaling pathway].. PubMed. 43(3). 246–252. 1 indexed citations
17.
Zuo, Tingting, Hongmei Zeng, Huichao Li, et al.. (2017). The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study. Chinese Journal of Cancer. 36(1). 84–84. 34 indexed citations
18.
Cheng, Gong, Changying Liu, Lei Zhang, et al.. (2015). Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition. Oncology Reports. 34(2). 987–994. 23 indexed citations
19.
Liu, Lifang, Yiming Zhang, Zihe Liu, Dina Petranović, & Jens Nielsen. (2015). Improving heterologous protein secretion at aerobic conditions by activating hypoxia-induced genes inSaccharomyces cerevisiae. FEMS Yeast Research. 15(7). fov070–fov070. 17 indexed citations
20.
Liu, Lifang, José L. Martínez, Zihe Liu, Dina Petranović, & Jens Nielsen. (2013). Balanced globin protein expression and heme biosynthesis improve production of human hemoglobin in Saccharomyces cerevisiae. Metabolic Engineering. 21. 9–16. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026